Nanologica AB

📍 Södertälje, Sweden🗓 Founded 2004👥 27 employees💰 Last funded May 2014
Biotechnology Research🌐 nanologica.com
Website LinkedIn
Nanologica is a Swedish biotechnology company developing nanoporous silica particles for applications within life science. The company is world-leading in controlling the shape, size, and type of porosity of silica particles, creating opportunities to develop unique products. Through the two business areas, Chromatography and Drug Development, the company strives towards increasing the accessibility for innovative treatments and medicines in healthcare, for the benefit of patients around the world. In Chromatography, the company aims to make insulin and other peptide-based drugs available to more patients in need by providing a purification product that lowers manufacturing cost by being more efficient and lasting longer than competitors. In Drug Development, Nanologica develops a unique drug delivery platform for local delivery of drugs to the lung. The platform for inhalation is developed to provide new treatment options for patients with severe lung diseases. Nanologica’s stock (NICA) is listed on Nasdaq Main Market. For further information, please visit www.nanologica.com.
2
Total investors
0
Early stage
0
Mid stage
1
Late stage
2004
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Sweden
2
Frequently asked questions
Who invested in Nanologica AB?
Nanologica AB has 2 investors on record on gritt.io and 1 late-stage investors.
When did Nanologica AB last raise funding?
The most recent investment in Nanologica AB recorded on gritt.io was in May 2014.
When was Nanologica AB founded?
Nanologica AB was founded in 2004.
What industry is Nanologica AB in?
Nanologica AB operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Nanologica AB based?
Nanologica AB is headquartered in Södertälje, Sweden.